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The oral route remains the preferred method for drug delivery due to high patient compliance and 
administration without the need for health care professionals. However, conventional dosage forms 
such as tablets and capsules are facing a number of limitations. Among others, the short retention 
time in the intestine is a challenge, in particular for drugs with low solubility and low permeability 
through the intestinal mucosa. This means that a considerable amount of the drug passes through the 
gastrointestinal tract (GIT) without being able to reach its target. Furthermore, degradation of the 
active pharmaceutical ingredient (API) has to be considered specifically in the case of protein or 
peptide based drugs. Microfabricated reservoir based devices have been proposed as advanced oral 
drug delivery system to potentially address some of these issues by preventing the degradation of 
drug and allowing unidirectional release in the GIT. Recently, first in vivo studies have shown 
promising results for prolonged release and enhanced bioavailability of drugs .
[1-4] 
The 
microreservoirs have conventionally been fabricated with Si and photoresists such as SU-8 and 
poly(methyl methacrylate) (PMMA) using standard micro-electro-mechanical systems (MEMS) 
fabrication technologies. 
[5, 6]
 Gradually, the focus has shifted to fabricating drug reservoirs in 
biodegradable polymers such as poly(lactic-co-glycolic acid) (PLGA).
[7,8]
 Once these 
microreservoirs are fabricated, drug loading imposes a major challenge. The loaded drug is 
preferentially embedded in a polymer matrix for stabilization and to tailor the release properties. 
The polymer matrices can be hydrophobic, slow-degrading biodegradable polymers such as poly-l-
lactic acid (PLLA) or poly-ɛ-caprolactone (PCL) for sustained drug release.[9] Alternatively, the 
drug matrices can be hydrophilic polymers or their gel forms such as poly acrylic acid (PAA) and 
poly vinyl pyrrolidone (PVP) for increased drug solubility and bioavailability.
[10, 11] 
In the past, 
microreservoirs have been loaded with drug-polymer matrices by using photolithography, 
microinjection and ink-jet printing.
[12-14]
 Supercritical CO2 (scCO2) has been introduced as a 
method to load drug in microreservoirs previously filled with polymer matrix by ink-jet printing.
[15]
 
Although aforementioned loading techniques provide good control on the amount of loaded drug, 
they suffer from some disadvantages. Photolithography typically uses UV light which can degrade 
the active pharmaceutical ingredients (API) and it is challenging to handle high molecular weight 
polymers and drugs. ScCO2 impregnation has some limitations because of limited solubility of 
APIs. Furthermore, the structural stability of microreservoirs fabricated in biodegradable polymers 
such as PLLA can be affected in scCO2. The common limitation with all these loading techniques is 
that they are relatively slow processes. Alternatively, microcontact printing has been developed as a 
fast process to fill a large number of microreservoirs in parallel.
[16]
 However, this technique requires 
fabrication of a polydimethylsiloxane (PDMS) stamp which is mechanically and chemically not 
sufficiently stable to perform a large number of loading runs.
[17]
 Microcontact printing also requires 
a set-up to align the stamp precisely to the microreservoirs.
[16]
 
In this paper, a new fast method for parallel loading of reservoir based microdevices called 
microcontainers is proposed and demonstrated. Each microcontainer includes a reservoir 
surrounded by a thin wall.The containers are fabricated in the negative epoxy photoresist SU-8 and 
in biopolymer PLLA to demonstrate the versatility of the drug loading method. SU-8 
microcontainers are fabricated using two-steps of photolithography on a fluorocarbon coated Si 
carrier substrate.
[18]
 PLLA microcontainers are fabricated using hot punching and transfer to a water 
soluble sacrificial layer deposited on Si substrate.
[19]
 The containers are produced as arrays on a 
fluorocarbon or sacrificial layer respectively to allow final release from the Si substrate. After the 
fabrication of microcontainers, the reservoirs of the containers are loaded with drug-polymer matrix 
using hot punching. Figure 1 illustrates the overall concept of drug loading in the two types of 
microcontainers. 
Hot punching is a combination of hot embossing and mechanical punching processes.
[19-21]
 Hot 
embossing is the process of achieving micropatterns in a viscoelastic polymer film placed on a 
carrier substrate when a mold is embossed into the film, through the application of external pressure 
and temperature. Mechanical punching process allows to produce through holes in a polymer film 
where the punched out polymer structures are basically the by-product of the process.
[22]
 During the 
hot punching process a mold is embossed in a polymer film at elevated temperature, separating the 
embossed polymeric microstructures from the rest of the film. Two conditions need to be 
considered during hot punching: i) either the mold or the substrate carrying the polymer film should 
locally display some elastic deformation upon application of the pressure. This provides the force 
required to rupture the polymer film and to allow mold and carrier substrate to come in physical 
contact and ii) the thickness of the polymer film has to be sufficiently high to fill the cavities of the 
mold but low enough to allow contact of the mold with the carrier substrate during the application 
of pressure. Once these conditions are satisfied, the hot punching process promotes disruption of the 
residual layer inherently present after a typical hot embossing process and thus leads to formation of 
discrete 3D microstructures. 
For the drug loading process of the microcontainers, the arrays of microcontainers on the substrate 
are considered as the mold (Figure 1.A.1 and 1.B.1). This microcontainer mold punches the drug-
polymer film spin coated on a substrate by applying temperature and pressure. A third condition 
needs to be fulfilled to successfully load the microcontainers: iii) the 3D drug-polymer 
microstructures that are punched out by the  microcontainermold during the hot punching process, 
have to remain in the microcontainers after demolding, thereby loading the containers. To ensure 
this, the work of adhesion Wpm between mold and drug-polymer film should be higher than the 
work of adhesion Wps between the drug-polymer film and the carrier substrate. For the proof-of-
concept, we selected the drug-polymer combination of furosemide (F), a loop diuretic drug, and 
biodegradable poly-ɛ-caprolactone (PCL) polymer as a model system.[23] The drug-polymer film (F-
PCL) is fabricated by spin coating a homogenous F-PCL solution on the substrate. The F-PCL film 
is punched by the SU-8 and PLLA microcontainermold during the hot punching process.  
In order to punch F-PCL film using thermally non-deformable rigid SU-8 microcontainers, the Si 
substrate is coated with PDMS before spin coating F-PCL solution (Figure 1.A.1). The elastically 
deformable PDMS film allows the contact of the mold and the substrate.
[18]
 For the punching of F-
PCL film by thermally deformable PLLA microcontainers, F-PCL solution is spin coated directly 
on Si without any additional PDMS layer (Figure 1.B.1). Here, the elastically deformable 
microcontainers themselves promote rupture of the residual layer. In order to fulfill the second 
condition for hot punching, the required thickness of the F-PCL film is calculated based on the 
dimensions of the microcontainers (Supporting information).  The thickness of the F-PCL film 
should be less than or equal to the thickness required to completely fill the microcontainer 
reservoirs without leaving a residual film. The critical dimensions of the containers are summarized 
in Table 1 and illustrated in Figure. B of Supporting information. The calculated optimal thickness 
of the F-PCL film for loading of SU-8 containers is 48 µm and for PLLA microcontainers it is 70 
µm. 
During the punching process, the F-PCL film is punched along the walls of the microcontainers 
through the application of pressure and temperature. The results are summarized in Figure 2. The 
hot punching of F-PCL film by SU-8 microcontainers is performed at a temperature of 65 ºC and a 
pressure of 1 bar. The temperature is applied on both plates of the embossing equipment in contact 
with the microcontainermold and the F-PCL sample. When the SU-8 containers punch the F-PCL 
film lying on PDMS (Figure 1.A.2), Wpm > Wps due to the hydrophobic properties of PDMS. Hence, 
the punched out F-PCL microstructures remain in the SU-8 reservoir and the SU-8 microcontainers 
are loaded (Figure 1.A.3, 2.A, 2.B and 2.C). Complete filling of reservoirs is achieved by spin 
coating F-PCL films with a thickness of around 46 ± 3 µm, which is in good agreement with the 
calculated film thickness of 48 µm.  
When the temperature of 65 ºC is applied to both plates of the embossing equipment for loading of 
F-PCL in PLLA microcontainers, the thermally deformable PLLA containers lose their structural 
integrity and are flattened. The glass transition temperature of PLLA is between 65-70  ºC
[24]
, and 
punching at a temperature lower than 65 ºC results in poor yield of loading.Consequently a 
temperature of 75 ºC is only applied to the plate in contact with the F-PCL sample while the plate 
with the PLLA containers remains at ambient temperature. Furthermore, the applied pressure is 
lowered to 0.5 bar in order to achieve good yield of loading without affecting the integrity of the 
containers(Figure 1.B.2). The F-PCL polymer film at 75 ºC, locally heats the PLLA upon contact 
during hot punching and blends with it at the interface.
[24, 25]
 This results in sufficiently high Wpm to 
ensure that the punched out F-PCL structures remain in the PLLA microcontainers after demolding, 
thereby loading them (Figure 1.B.3, 2. D, 2.E and 2.F).  
Optical profiler measurements show a filling height of 61 µm and indicate that the PLLA containers 
remain structurally intact (Figure 2.G and H). Successful loading is achieved even for a F-PCL 
film thickness as low as 43±3 µm which is considerably below the calculated optimal value of 70 
µm. This is explained by the high Wpm and polymer reflow during punching of the F-PCL film in a 
molten state. High replicability and yield of > 95% are observed for the loading of both SU-8 and 
PLLA microcontainers. 
The model system of F-PCL matrix loaded in the microcontainers by hot punching is characterized 
by performing X-Ray Powder Diffraction (XRPD) and Raman spectroscopy. The furosemide 
release is studied by microdissolution. For the sake of simplicity, XRPD and Raman data for F-PCL 
loaded in PLLA microcontainers is presented here. The results confirm that both PCL and 
furosemide are loaded in the microcontainers. Furosemide is present in polymorph form I which is 
the most common and the most stable of all the polymorphs due to more efficient crystal packing, 
higher density and the presence of sulfonamide groups.
[23]
 The spectra taken for the pure 
furosemide crystals show the same spectra of polymorph form I indicating that the furosemide 
remains in the most stable form during the punching process as illustrated in Figure 3.A.
[24]
 The 
sharp furosemide peaks especially at 1600 cm
-1
 and 1509 cm
-1
 in raman data and at 25º 2θ in XRPD 
show that furosemide is present in semi-crystalline form (Figure 3.A and B).
[26, 27]
 
Microdissolution study depicted in Figure 3.C, illustrates the release of furosemide from the PCL 
matrix loaded in PLLA microcontainers using hot-punching. The release profile of furosemide 
shows an initially fast release followed by a slower sustained release. The weight of 
microcontainers is measured before and after the loading, giving an estimate of the amount of drug 
present in a container. Based on this, around 80% of furosemide is released from the PCL matrix 
after 7 hrs of dissolution. PCL matrix promotes the controlled release of furosemide as no 
degradation or erosion occurs in the time span of 7 hrs.
[28]
  
In conclusion, we here demonstrate hot punching as a new efficient process of loading drug-
polymer matrix in microreservoirs. The advantages of the hot punching process for loading of 
micro-reservoir based oral drug delivery devices are: i) it is a versatile process that can be used to 
load different combinations of drug and polymer; ii) the process is a single-step, parallel process 
with high throughput; iii) no specialized printing or alignment tools and advanced processing 
conditions are required which is promising for future scale up; iv) hot punching is a comparatively 
benign process towards the drug; v) it can be used for filling of high-aspect ratio structures. A 
potential limitation of the process is the application of elevated temperature, which might affect 
some APIs. Furthermore, we have shown successful release of drug from microcontainers 
completely manufactured in biodegradable polymers.  
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Experimental 
1. Materials  
Standard 4-inch single crystal (SC) silicon wafers are supplied by Okmetic (Vantaa, Finland). 
Sylgard 184 from Dow Corning is used to prepare PDMS. The prepolymer and the curing agent are 
mixed in 10:1 ratio. For the experiments, PLLA 2003D grade is purchased from Natureworks 
(Minnetonka, Minnesota), with Mw = 126,000Da, determined by size exclusion chromatography 
measurements. Dichloromethane (DCM) (anhydrous > 99.8%), poly Acrylic Acid (PAA, average 
Mw ~ 1,800) powder, polyethylene glycol pellets (PEG, average Mn = 6,000), polycaprolactone 
pellets (average Mw ~ 100,000) and phosphate buffer saline tablets (pH 7.4) are obtained from 
Sigma Aldrich (Copenhagen, Denmark). Furosemide (⩾ 98% purity) is supplied by  Sigma–Aldrich 
(St. Louis, MO, USA). SU-8 2075 and SU-8 developer are purchased from Microresist Technology 
GmbH (Berlin, Germany). The chromium mask is designed using L-Edit from Tanner EDA 
(Monrovia, CA, USA) and supplied by DeltaMask B.V. (GJ Enschede, The Netherlands).  
2. Methods  
2.1. Loading of microcontainers using hot punching 
First the SU-8 microcontainers and PLLA microcontainers are fabricated using photolithography 
and hot punching (process B), respectively. For the easy release of the microcontainers, SU-8 
fabrication is performed on fluorocarbon coating while PLLA microcontainers are bonded to water 
soluble sacrificial layer of PAA-PEG. Detailed description of the fabrication process of the 
containers can be found in the earlier papers [14, 18]. For loading of F-PCL, first a homogenous 
solution is prepared. 8 g of PCL and 2 g of furosemide are dissolved in 40 ml of Acetone and 20 ml 
of DCM producing a 14.7 %  wt. solution. The solution is stirred overnight at room temperature. 
In order to load SU-8 microcontainers with F-PCL, F-PCL solution is spin coated at 500 rpm on 
PDMS deposited Si wafer to give 22 ± 2 µm thick layer. This process is repeated twice to achieve a 
final thickness of 46 ± 3 µm. This spin coated wafer is kept overnight for the evaporation of DCM. 
Once the DCM solvent evaporates from the PCL layer, it is brought in contact with the SU-8 
microcontainers. The punching is done by applying a temperature of 65 ºC and pressure of 1 bar for 
30 min to both the upper and lower plates of the embossing tool. The molten F-PCL fills the SU-8 
container at this stage. The hot plates are cooled down to 35 ºC and the SU-8 containers are 
demolded. The punched F-PCL detaches from the surrounding F-PCL film and remains attached to 
the SU-8 container, thus filling them. 
In order to load PLLA microcontainers with F-PCL, the same 14.7 % wt. solution is spin coated 
twice at 500 rpm as before to achieve 46 ± 3 µm film thickness. Once DCM evaporates, the hot 
punching of the F-PCL film by the PLLA microcontainers is done by applying a higher temperature 
of 75 ºC. This temperature is applied for 30 min to the plate in contact with the F-PCL sample only 
in order to protect the structural integrity of PLLA microcontainers. A lower pressure of 0.5 bar 
required to bring the F-PCL sample and microcontainers in contact is applied and demolding is 
performed at 35 ºC. 
2.2. Scanning electron microscopy and optical profilometry 
The cross-sectional profile measurements of the microcontainers are acquired using confocal mode 
(20X) in optical profilometry (Sensofar PLu Neox 3D). The samples are characterized using SEM 
Zeiss Supra 40 VP in variable pressure mode at 8 kV operating voltage and 13 Pa pressure.  
2.3. Raman spectroscopy and X-Ray diffraction measurements 
Raman spectra are collected from the F-PCL loaded PLLA microcontainers with a DXR Raman 
microscope (Thermo Scientific, Germany) equipped with a frequency-stabilized single mode diode 
laser (780 nm). The laser power is set to 24 mW at the sample position (center of the container) and 
the estimated resolution is 2.4 – 4.4 cm−1. An exposure time of 30 s and 3 scans are used. The X-ray 
powder diffraction (XRPD) study is carried out to characterize the physical state of the drug 
embedded in the PCL matrix loaded in the PLLA microcontainers. All XRPD analyses are 
performed using an X'Pert PRO X-ray diffractometer (PANalytical, Almelo, The Netherlands; MPD 
PW3040/60 XRD; Cu KR anode; λ = 1.541 Å; 45 kV; 40 mA). A starting angle of 5° 2θ and an end 
angle of 35° 2θ are employed for the scans. A scan speed of 0.6565° 2θ/min and a step size of 
0.01313° 2θ are employed. Data are collected using the X'Pert Data Collector software 
(PANalytical B.V.).  
2.4. In vitro drug dissolution studies 
Dissolution of furosemide from PCL loaded in PLLA microcontainers is measured in 10 ml 
phosphate buffer media (pH 7.4) at 37.5 °C using a μDISS profiler (Pion) for 7 hrs. The media is 
prepared by dissolving the buffer capsule in 200 mL water. For dissolution experiments, PLLA 
containers are bonded to PLLA layer instead of sacrificial water soluble PAA-PEG layer in order to 
avoid release of the microcontainers from the substrate during measurements and interference with 
the UV probe. The PLLA layer after being loaded with drug-polymer matrix is peeled from Si 
substrate and cut into individual samples for each of the six probes of μDISS profiler. Each sample 
is first glued with carbon pad on teflon-coated magnetic stirrer.  
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Figure 1. Hot punching for loading of microcontainers with drug-polymer matrices: A. Drug-
polymer loading in SU-8 microcontainers by hot punching on deformable substrate: 1. Fabrication 
of SU-8 microcontainers on fluorocarbon coating and preparation of the sample by spin coating 
drug-polymer solution on PDMS coated Si. 2. Hot punching drug-polymer by SU-8 microcontainer-
mold, 3.Demolding of the containers with attached drug-polymer matrices punched out from rest of 
the film, B. Drug-polymer loading in PLLA microcontainers: 1. Fabrication of PLLA 
microcontainers bonded on water soluble poly acrylic acid (PAA) - polyethylene glycol (PEG) 
sacrificial layer and preparation of the sample by spin coating drug-polymer solution directly on Si. 
2. Hot punching drug-polymer by PLLA microcontainer-mold, 3.Demolding of the containers with 
attached drug-polymer matrices punched out from rest of the film and loading of the containers. 
  
 
Figure 2. SEM micrographs of: A. Empty SU-8 microcontainers B/C. F-PCL loading in SU-8 
microcontainers using optimized parameters; D.Empty PLLA microcontainers E/F. F-PCL loading 
in PLLA microcontainers; Optical profiler measurements of G. empty, and H. F-PCL loaded PLLA 
microcontainers along with the 3D images. 
Loading SU-8 microcontainers Loading PLLA microcontainers
Si substrate Drug-Polymer matrix Fluorocarbon coating
PDMS elastic layer
SU-8 microcontainers
PAA-PEG sacrificial layer PLLA microcontainers
BA
I. Sample preparation
II. Hot punching
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II. Hot punching
III. Demolding
65 C
75 C
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Figure 3. A. Raman Spectra B. X-ray diffractometry of F-PCL matrix loaded in PLLA 
microcontainers, only PCL polymer loaded in PLLA microcontainers and crystalline furosemide 
powder. C. Dissolution release of Furosemide from PCL matrix loaded in PLLA microcontainer.  
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Table 1. Dimensions of SU-8 and PLLA microcontainers 
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SUPPORTING INFORMATION 
Container
Depth of 
reservoir,
(µm)
Diameter of 
reservoir,
(µm)
Height of 
container, 
(µm)
Diameter of 
container,
(µm)
Center-to-center 
distance between
containers, L (µm)
SU-8 60 200 100 300 450
PLLA 73 240 100 300 600
Calculation of required polymer film thickness  
In hot embossing, the total amount of polymer volume (Vfill) that is required to fill the cavities in the 
stamp can be calculated assuming that the volume of the polymer is constant. Figure. A is the 
schematic representation of a typical stamp.  
 
Figure. A. Schematic representation of a typical stamp. 
If the highest elevated feature on the stamp has a height, Hf, the total surface area to be filled on the 
stamp is A, the volume of a negative feature is Vneg and the volume of a positive feature is Vpos.  
 𝑉𝑓𝑖𝑙𝑙 = 𝐴𝐻𝑓 +  ∑ 𝑉𝑛𝑒𝑔 − ∑ 𝑉𝑝𝑜𝑠 
(1) 
If the volume of the residual layer with thickness Hres is taken into account, then the volume V0 of 
the initial polymer layer is: 
 𝑉0 = 𝐴𝐻𝑟𝑒𝑠 +  𝑉𝑓𝑖𝑙𝑙 (2) 
This implies that the initial thickness, H0 of the polymer that has to be spin coated to achieve 
complete filling of the mold is: 
 
𝐻0 = 𝐻𝑟𝑒𝑠 + 
𝑉𝑓𝑖𝑙𝑙
𝐴
 
(3) 
Polymer StampSubstrate
In hot punching, the thickness of the residual layer is assumed to be Hres = 0. This means that H0 
can be derived by the total volume of the cavities. To be able to successfully disrupt the residual 
layer, the thickness of the spin coated film should be slightly lower than H0. In that case polymer  
  
Figure. B. Schematic of hot punching of drug-polymer matrix by microcontainer-mold; C. Top view 
of the microcontainer chip 
fluid can be completely confined in cavities of the mold and the highest protrusions of the stamp 
can achieve conformal contact with the substrate below the polymer. This thickness is the 
maximum thickness, Tmax of polymer film for hot punching. From Figure. B and C, and Table 1, A. 
assuming that the microreservoirs of the containers are completely filled, that is the drug-polymer 
matrix is filled to HR, 
SubstrateB
Microcontainer mold
HR
L
DµCDR
HµC
Drug-Polymer
C
 
𝐿2𝑇max = 𝐿
2𝐻R −  𝜋𝐻𝑅 (
𝐷µC
2 − 𝐷R
2
4
) 
(4) 
This implies that the maximum thickness (Tmax) of the F-PCL films required is given by: 
 
𝑇max = 𝐻R {1 −
𝜋
4
(
𝐷µC
2 − 𝐷R
2
𝐿2
)} 
(5) 
 
 
 
 
